US Stock MarketDetailed Quotes

RARE Ultragenyx Pharmaceutical

Watchlist

40.800
-1.040-2.49%

Close Feb 25 16:00 ET

40.800
0.0000.00%

Post 16:20 ET

3.77BMarket Cap-6.49P/E (TTM)

Ultragenyx Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ultragenyx Pharmaceutical Q4 2024 Earnings Date

Currency：USDFeb 13, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	158.71M	164.88M	+6.17M
Beat Est.	+24.58%	+29.42%	+3.89%
EPS	-1.29	-1.39	-0.10
Miss Est.	+15.12%	+8.55%	-7.74%

Analyst Rating

Strong Buy

Feb 25, 2025

Ultragenyx Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 16 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 163.669M	--
--	2025/Q1	-- / 145.980M	--
Feb 13, 2025	2024/Q4	164.877M / 158.706M	--
Nov 5, 2024	2024/Q3	139.494M / 135.247M	--
Aug 1, 2024	2024/Q2	147.026M / 123.214M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 163.669M--

--2025/Q1-- / 145.980M--

Feb 13, 20252024/Q4164.877M / 158.706M--

Nov 5, 20242024/Q3139.494M / 135.247M--

Aug 1, 20242024/Q2147.026M / 123.214M--

Unlock Free Earnings Estimates

Open Account

Ultragenyx Pharmaceutical Earnings Reports

Ultragenyx Pharmaceutical | 10-K: FY2024 Annual Report

Feb 19 17:02 ET

Ultragenyx Pharmaceutical | 8-K: Ultragenyx Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Update

Feb 13 16:11 ET

Ultragenyx Pharmaceutical | 10-Q: Q3 2024 Earnings Report

Nov 6, 2024 13:11 ET

Ultragenyx Pharmaceutical | 8-K: Ultragenyx Reports Third Quarter 2024 Financial Results and Corporate Update

Nov 5, 2024 16:13 ET